DAP:ETR
Danaher Corp
€ २०७.८०
arrow_upward
+०.१४%(+०.३०) 1D
अक्टोबर २७, १७:३५:३० GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
€ २०७.३०
High
€ २०९.२०
Low
€ २०७.३०
Mkt. cap
१.६३ खरब
Avg. vol.
५६६.००
Volume
१.११ हजार
52-wk high
€ २१०.३०
52-wk low
€ १३८.२०
No. of employees
५९ हजार
Open
€ २०७.३०
High
€ २०९.२०
Low
€ २०७.३०
Mkt. cap
१.६३ खरब
Avg. vol.
५६६.००
Volume
१.११ हजार
52-wk high
€ २१०.३०
52-wk low
€ १३८.२०
No. of employees
५९ हजार
News stories
From web sources and news partners
FinancialContent
·
१ घण्टा पहिले
Rogers (NYSE:ROG) misses Q3 2026 sales expectations
CUToday
·
३९ मिनेट पहिले
CU-Spun-Off Safe Harbor Faces Change In Control Under Proposed Deal to Preserve Nasdaq Listing
MarketWatch
·
१८ मिनेट पहिले
The rest of the market is leaving Big Tech behind after a historic comeback
Reuters
·
२ घण्टा पहिले
NYSE moves to bring all-or-nothing options to stocks and company earnings
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp